NCT07151781

Brief Summary

The goal of this clinical trial is to learn if a video-guided mindfulness intervention can improve prenatal depression symptoms, improve mental health-related quality of life, reduce the risk of maternal postpartum depression and paternal postpartum depression, and improve neonatal birth outcomes in a resource-constrained setting. This clinical trial will be conducted in pregnant women. The main questions it aims to answer are:

  • Can video-guided mindfulness intervention be effective for prenatal depression treatment as compared to routine care?
  • Is there a dose-response relationship between the length of a video-guided mindfulness intervention and a reduction in prenatal depression symptoms?
  • Does a video-guided mindfulness intervention improve mental health-related quality of life more effectively than routine care?
  • What is the impact of intervention duration on the effectiveness of a video-guided mindfulness intervention for improving mental health-related quality of life?
  • Can a video-guided mindfulness intervention during pregnancy lead to improved neonatal birth outcomes compared to standard care?
  • Can a video-guided mindfulness intervention during pregnancy reduce the risk of developing prenatal depression compared to routine care?
  • Can the treatment of maternal prenatal depression through a video-guided mindfulness intervention reduce the risk of paternal postpartum depression? Researchers will compare the intervention group with a group of pregnant women who screen positive for prenatal depression but continue to receive only routine antenatal care, in order to evaluate differences in prenatal depression symptoms, improvements in mental health-related quality of life, reductions in the risk of maternal and paternal postpartum depression, and improvements in neonatal birth outcomes. Participants (the intervention group) will receive a video-guided mindfulness intervention that they will listen to for eight weeks at their nearest health center three times a week.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 3, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 3, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

August 19, 2025

Last Update Submit

August 25, 2025

Conditions

Keywords

mHealthmindfulnessprenatal depressionrandomized controlled trialhealth technologyRCT

Outcome Measures

Primary Outcomes (1)

  • Prenatal Depression Symptoms

    The symptoms of prenatal depression will be measured using the Edinburgh Postnatal Depression Scale. The EPDS is a widely validated 10-item self-report questionnaire designed to screen depressive symptoms primarily in the postnatal period and later extended for prenatal period depression symptoms. The study participants will be asked to report their relevant rating scale out of the available four response options with the EPDS. They will be asked about their experience of the symptoms over the past seven days. The higher score, which is three, indicates greater levels of depressive symptoms, and a zero score shows the absence of the symptoms. The maximum total score in EPDS is 30, where a cut-off score of ≥13 in clinical and research settings is used to indicate positive screened for PND.

    The primary outcome will be assessed immediately after the intervention is done; after eight weeks of the initiation of the intervention.

Secondary Outcomes (1)

  • Better Mental Health Related Quality of Life

    Mental Health Related Quality of Life will be evaluated immediately after intervention (After eight weeks).

Other Outcomes (3)

  • Symptoms of maternal postpartum depression

    Symptoms of maternal postpartum depression will be measured at the ninth week from initiation of intervention.

  • Symptoms of paternal postpartum depression

    Symptoms of paternal postpartum depression will be measured at the ninth week from initiation of intervention.

  • Neonatal birth outcome

    Neonatal birth outcome will be assessed at the ninth week from initiation of intervention.

Study Arms (2)

Intervention arm

EXPERIMENTAL

The intervention arm will receive a video-guided mindfulness practice consisting of audio recordings (in two local languages: Afan Oromo and Amharic) combined with familiar natural environment visuals. The exercise instruction consists of three core mindfulness practices: (i) Focus the Mind: to cultivate present-moment attention and reduce cognitive rumination; (ii) Breath Awareness: to anchor attention and promote relaxation; and (iii) Basic Body Scan: to encourage non-judgmental awareness of bodily sensations to enhance their mind-body connection. The intervention will be delivered face-to-face at the health centers using a smartphone-based video. The intervention is planned to be delivered regularly according to a standardized schedule for each of the women individually. Each session of the exercise can last for about 21-23 minutes. Hired Midwifery Nurses at each of the health centers will support the woman to start the exercise and follow her till the end of the sessions daily.

Other: Video-guided Mindfulness Exercise

Control group

NO INTERVENTION

The control group will continue with the routine maternal and other standard health care services as provided by the health centers in accordance with national maternal health guidelines. In Ethiopia, according to the National Antenatal Care Guideline 2022, each woman must visit the health facility for eight contacts. They are expected to screened for potentially recurring obstetric complications such as recurrent pregnancy loss, preterm labor, pre-eclampsia/eclampsia, gestational diabetes, congenital anomaly, puerperal psychosis, obstetric and gynecologic surgery, immunologic disorders, medical and mental health disorders, infectious diseases, physical disability and developmental disorders, nutritional history, social and personal history, current medication, and intimate partner violence. They receive counselling on the risk of pregnancy, contraception, micronutrient supplementation, weight gain monitoring, counselling on the increased risk to the fetus, and other related services.

Interventions

Mindfulness interventions are emerging as effective, low-risk approaches to managing depression and enhancing emotional and maternal well-being in pregnant women. Rooted in ancient meditative practices that originated from Buddhist religion and traditions and adapted for clinical use, mindfulness intervention cultivates present-moment awareness and nonjudgmental acceptance of thoughts, emotions, and bodily sensations. Mostly, mindfulness interventions include elements such as mindful breathing and body scanning and have shown effectiveness in reducing depressive symptoms and enhancing emotional regulation. It is the ability to maintain attention to an immediate experience with a sense of adopting an open and accepting attitude toward that experience. However, further research is important to evaluate its effectiveness across diverse sociodemographic and socioeconomic settings.

Intervention arm

Eligibility Criteria

Age15 Years - 49 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pregnant women who lived in Jimma City for at least six months
  • Women with a gestational age between 12 and 28 weeks,
  • Women who scored EPDS ≥ 13,
  • Willing to participate for eight consecutive weeks,
  • Able to attend the health center three times per week and gave consent to be followed up by study supervisors and data collectors

You may not qualify if:

  • Having been diagnosed with mental health disorders or eating disorders,
  • Active substance use,
  • EPDS item 10 score ≥1 or total EPDS score \>19,
  • Currently receiving pharmacological or psychotherapeutic treatment,
  • Regularly practice meditation,
  • Severely ill,
  • Has active pregnancy-related complications that could interfere with attending the mindfulness exercise, or neurological conditions such as epilepsy or seizures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jimma City in the Southwestern part of Ethiopia, 353 km away from the capital city, Addis Ababa.

Jimma, Ethiopia

Location

Related Publications (2)

  • Worku BT, Abdulahi M, Amenu D, Bonnechere B. Effect of technology-supported mindfulness-based interventions for maternal depression: a systematic review and meta-analysis with implementation perspectives for resource-limited settings. BMC Pregnancy Childbirth. 2025 Feb 13;25(1):155. doi: 10.1186/s12884-025-07286-9.

    PMID: 39948517BACKGROUND
  • 1. Molenaar NM, Kamperman AM, Boyce P, Bergink V. Guidelines on treatment of perinatal depression with antidepressants: an international review. Australian & New Zealand Journal of Psychiatry. 2018;52(4):320-7. 2. Leng LL, Yin XC, Ng SM. Mindfulness-based intervention for clinical and subthreshold perinatal depression and anxiety: a systematic review and meta-analysis of randomized controlled trial. Comprehensive Psychiatry. 2023;122:152375. 3. Min W, Jiang C, Li Z, Wang Z. The effect of mindfulness-based interventions during pregnancy on postpartum mental health: a meta-analysis. J Affect Disord. 2023;331:452-60. 22. Marlatt GA. Buddhist philosophy and the treatment of addictive behavior. Cogn Behav Pract. 2002;9(1):44-50. 4. Kabat-Zinn J. Mindfulness-based stress reduction (MBSR). Constructivism in the human sciences. 2003;8(2):73.

    BACKGROUND

Study Officials

  • Bruno Bonnechere, PhD

    Hasselt University

    PRINCIPAL INVESTIGATOR
  • Misra Abdulahi, PhD

    Jimma University

    PRINCIPAL INVESTIGATOR
  • Demissew Amenu Sori, PhD

    Jimma University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bekelu Teka Worku, Master of Public Health (MPH)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
Data collectors Participants in the control arm
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized controlled trial (RCT) with a 1:1 allocation ratio will be used to compare a video-guided mindfulness intervention group with a standard care control group. Study participants will be recruited at the community level. Pregnant women will be identified and registered by a team called "Gaachana", a local volunteer group working under the supervision of Health Extension Workers (HEWs). Screening for PND will be conducted using the Edinburgh Postnatal Depression Scale (EPDS) by trained data collectors until the required sample size is achieved. Eligible participants will be randomly assigned to either the intervention or control group.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 19, 2025

First Posted

September 3, 2025

Study Start

November 1, 2025

Primary Completion

December 30, 2025

Study Completion

December 31, 2025

Last Updated

September 3, 2025

Record last verified: 2025-08

Locations